28 results
Thumbnail

D2.33 - Complex occupational allergic contact dermatitis: polysensitization in a worker exposed to metals, adhesives, and plastics

Thumbnail

D2.34 - Pediatric allergic contact cheilitis associated with propolis sensitization

Thumbnail

D2.35 - Occupational Protein Contact Dermatitis to Latex Compromising Fitness for Work in a Nurse

Thumbnail

D2.37 - Occupational Allergic Dermatoses of the Face: Allergen Distribution and Work-Related Outcomes

Thumbnail

D2.38 - Occupational Exposure to Propolis: A Rare Cause of Allergic Contact Dermatitis in Textile Workers

Thumbnail

D2.39 - Occupational Contact Dermatitis with Polysensitization to Metals: Challenges for Work Fitness and Prevention

Thumbnail

D2.40 - Occupational allergic contact dermatitis to metals: clinical features and impact on work fitness

Thumbnail

D2.41 - Production of recombinant Cuc ma 5: A Step Towards Molecular Diagnosis of Pumpkin Seed Allergy

Thumbnail

D2.42 - Evaluation of User Experience with a Skin Prick Automated Test (SPAT) Device compared to a Manual Skin Prick Test (SPT) in Pediatric Patients

Thumbnail

D2.30 - A Case of Kimura’s Disease with Atypical Presentation and Novel Genetic Findings

Thumbnail

D2.31 - A Case of Acquired C1 Inhibitor Deficiency Angioedema with Anti-C1q Antibodies in Systemic Lupus Erythematosus and Negative Exome Sequencing

Thumbnail

D2.32 - A Positive Drug Challenge to Amoxicillin and Clavulanate (AMX) in a Child, Six Years After the Initial Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE)

Thumbnail

D3.418 - A Phase 1b Study of Lesigercept, a Long-acting High-affinity IgETrap-Fc Fusion Protein: Safety, Tolerability, PK, and PD in Atopic Healthy and Allergic Subjects

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.421 - Real-world Effectiveness and Safety of Lanadelumab Treatment in Patients With Hereditary Angioedema: The 12-Month Interim Analysis of a Polish, Prospective, Multicenter, Observational Study (CHOPIN)

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.423 - Lanadelumab treatment is effective and safe in patients with Factor XII associated cold-induced autoinflammatory syndrome: results from an open-label proof-of-concept study

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria

Thumbnail

D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project